Permitting patients to pay for participation in clinical trials: the advent of the P4 trial

In this article we explore the ethical issues raised by permitting patients to pay for participation (P4) in clinical trials, and discuss whether there are any categorical objections to this practice. We address key considerations concerning payment for participation in trials, including patient aut...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaw, David, de Wert, Guido, Dondorp, Wybo, Townend, David, Bos, Gerard, van Gelder, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2016
Materias:
Scientific Contribution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487744/
https://www.ncbi.nlm.nih.gov/pubmed/27757784
http://dx.doi.org/10.1007/s11019-016-9741-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487744/
https://www.ncbi.nlm.nih.gov/pubmed/27757784
http://dx.doi.org/10.1007/s11019-016-9741-2

Ejemplares similares